Genetically engineered white blood cells could be the future of HIV treatment | The Verge - 0 views
-
Scientists have successfully modified the white blood cells of 12 patients living with HIV, making their cells resistant to the retrovirus and improving the study participants' overall ability to fight off infection. The researchers achieved this result through a gene editing technique, described today in
-
Unlike the child who went into HIV remission a year ago, the patients in this study continue to test positive for HIV. But the results of this Phase I clinical trial still represent a promising debut for HIV treatments involving tailored gene therapy, as the white blood cells persisted for nearly a year after transfusion.
